1. Prenatal Diagnosis & Screening – Introduction
1.1 Prologue to Prenatal Diagnosis & Screening
1.2 Historical Insight to Prenatal Diagnosis in India
2. Need & Importance of Prenatal Diagnosis from an Indian Perspective
2.1 Increasing Prevalence of Prenatal Abnormalities
2.2 Increasing Burden of Birth Defects & Mortality
2.3 Rise in Prenatal Disorder Risk Factors in India
2.3.1 Maternal Age at Conception
2.3.2 Proportion of unplanned pregnancies and Lack of antenatal care
2.3.3 Early Marriage & Genetic Condition of the Mother
2.3.4 Rate of Consanguineous Marriage in Population
2.3.5 Exposure of Mother to Possible Teratogens
2.4 Trending of the (Double Income, Single Child) DISC Norm in Indian Society
2.5 Increase in Infertility Rates & In-Vitro Fertilization Centers
3. Non Invasive Prenatal Diagnosis – High Accuracy with No Risks
3.1 Overview
3.2 Risk Associated with Traditional prenatal Screening Methods
3.3 Comparative Analysis of NIPT with other Prenatal Screening Methods
4. Non-Invasive Prenatal Testing Market by Application
4.1.1 Down’ Syndrome (Trisomy 21)
4.1.2 Edwards Syndrome (Trisomy 18)
4.1.3 Patau’s Syndrome
4.1.4 Other Chromosomal Abnormalities
5. Superiority of Non Invasive Prenatal screening to Traditional Screening Test
5.1 Painless Procedure with Multiple Benefits
5.2 High Accuracy Even at Earlier Stage of Pregnancy
5.3 No Risk to the Developing Fetus, No Risk of Miscarriage
5.4 Much Higher Detection Rate with Minimum False Positives
6. India Non Invasive Prenatal Market Analysis by Product
6.1 MaterniT21
6.2 Harmony Test
6.3 Visibilit Test
6.4 NIFTY
6.5 Next Generation Sequencing (NGS) System
6.6 Panorama Test
6.7 Polymerase Chain Reaction (PCR) Instrument
6.8 Prenatal Chromosomal Microarray
6.9 Ultrasound & Other Device
7. Non Invasive Prenatal Market Analysis by Techniques
7.1 Ultrasound Detection
7.2 Biochemical screening tests
7.2.1 Human Chorionic Gonadotropin Test
7.2.2 Estriol & Inhibin A Screening
7.3 Cell-free DNA in Maternal Plasma Tests
8. Noninvasive Prenatal Testing Market by End User
8.1 Hospitals
8.2 Laboratories
8.3 In-Vitro Fertilization & Clinics
9. Driving Factors of the Noninvasive Prenatal Testing Market in India
10. Non Invasive Prenatal Testing Market Challenges in India
11. Future Forecast of the Noninvasive Prenatal Testing Market in India
12. Competitive Analysis – Indian NIPT Players
12.1 DNA Labs India
12.1.1 Company Overview
12.1.2 NIPT Products, Services & Cost Analysis
12.2 LifeCell
12.2.1 Company Overview
12.2.2 NIPT Products, Services & Cost Analysis
12.3 LifeCodexx AG
12.3.1 Company Overview
12.3.2 NIPT Products, Services & Cost Analysis
12.4 Apollo Centre for Fetal Medicine, New Delhi
12.4.1 Company Overview
12.4.2 NIPT Products, Services & Cost Analysis
12.5 Medgenome
12.5.1 Company Overview
12.5.2 Product, Services & Cost Analysis
12.6 Igenomix India
12.6.1 Company Overview
12.6.2 Products, Services & Cost Analysis
12.7 Fortis Healthcare Limited
12.7.1 Company Overview
12.7.2 Products, Services & Cost Analysis
12.8 DNA Forensics, India
12.8.1 Company Overview
12.8.2 Products, Services & Cost Analysis
Figure 1-2: Prenatal Diagnosis in India- History
Figure 2-1: Need & Importance of Prenatal Diagnosis in India
Figure 2-2: Prenatal Diagnosis- Benefits
Figure 2-3: Cause of High Prevalence of Prenatal Disorders in India
Figure 2-4: India – Neonatal Cases of Genetic Disorders (Number of Births), 2015
Figure 2-5: India - Prenatal Mortality due to Congenital Factors (Number/Year)
Figure 2-6: Prenatal Disorders - Risk Factors
Figure 2-7: India - Occurrence of Down's syndrome by Mother’ Age (per 10,000 Births)
Figure 2-8: India - Number of Females Married Before 18, 2014-2016
Figure 2-9: Possible Teratogens That Might Cause Prenatal Abnormalities
Figure 2-10: India - Annual Congenital Malformation (per 10,000 Births), 2015
Figure 2-11: Benefits of Double Income Single Child Norm
Figure 2-12: India – Number of NIPT Test at 10% Adoptability Rate of New Birth (Million) 2018 – 2024
Figure 2-13: India - Number of NIPT Test at 15% Adoptability Rate of New Birth (Million) 2018 – 2024
Figure 2-14: India – Number of NIPT Test at 20% Adoptability Rate of New Birth (Million) 2018 – 2024
Figure 2-15: India – Number of NIPT Test at 30% Adoptability Rate of New Birth (Million) 2018 – 2024
Figure 2-16: Major Factors for Rising Infertility in Indian Couples (%), 2018
Figure 2-17: India - Prevalence of Infertility by Region (%), 2017
Figure 2-18: Global - Infertility status by Region (%), 2018
Figure 3-1: Illustration of Non-Invasive Prenatal Screening Test
Figure 3-2: Goals of Non-invasive Prenatal Screening
Figure 3-3: Comparative Accuracy Analysis - NIPT v/s Other Screening Tests
Figure 3-4: Risks in Amniocentesis & Chorionic Villi Sampling
Figure 3-5: Comparative Cost Analysis - NIPT v/s Other Screening Test (INR), 2018
Figure 3-6: Comparative Cost Analysis - NIPT v/s Other Screening Test(US$), 2018
Figure 4-1: India - NIPT Market Size by Application (%) 2018
Figure 5-1:Non-invasive Prenatal Screening v/s Traditional Screening
Figure 6-1: NIPT Market Size by Product (%), 2018
Figure 6-2: Harmony Test - Price Analysis (INR & US$), 2018
Figure 6-3: Visibility Test - Price Analysis (US$ & INR), 2018
Figure 6-4: NIFTY - Cost Analysis (INR & US$), 2018
Figure 6-5: Genome Sequencing - Cost Analysis (US$ & INR), 2018
Figure 6-6: Panorama Test - Price Analysis (INR & US$), 2018
Figure 6-7: Prenatal PCR - Cost Analysis (INR & US$), 2018
Figure 6-8: Microarray - Cost Analysis (INR & US$), 2018
Figure 6-9: 3D Ultrasound Test - Cost Analysis (US$ & INR), 2018
Figure 6-10: 4D Ultrasound Test - Price Analysis (INR & US$), 2018
Figure 7-1: NIPT - Market Analysis by Techniques (%), 2018
Figure 7-2: MSAFP - Cost Analysis (INR & US$), 2018
Figure 7-3: HCG Biochemical Test - Cost Analysis (INR & US$), 2018
Figure 7-4: Estriol, Inhibin A- Test Cost Analysis (INR & US$), 2018
Figure 8-1: India - NIPT Market Size by End Users (%), 2018
Figure 9-1: Driving Factors of the Indian Prenatal Testing Market
Figure 10-1: Growth Restraining Factors of the Indian Prenatal Testing Market
Figure 11-1: India - Invasive v/s NIPT Market Size (%), 2018
Figure 11-2: India – Prenatal (Invasive & Non Invasive) Test Market Growth Forecast (US$ Million), 2018-2025
Figure 11-3: India Non Invasive Prenatal Test Market Forecast (US$ Million), 2018-2024
Figure 12-1: DNA Labs India - Service & Cost Analysis, 2018
Figure 12-2: Life Cell - Service & Price Analysis, 2018
Figure 12-3: LifeCodexx AG - Service & Cost Analysis, 2018
Figure 12-4: Medgenome - Product Service & Cost Analysis, 2018
Figure 12-5: Igenomix India - Service & Price Analysis, 2018
Figure 12-6: Fortis Healthcare Limited - Products & Service Price Analysis, 2018
Figure 12-7: DNA Forensics - Products & Services Price Analysis, 2018
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
